The phrase references a business model operating within the pharmaceutical sector, specifically one that purports to facilitate access to medications, often focusing on international sourcing, particularly from Canada. These entities typically position themselves as intermediaries between patients and pharmacies, aiming to offer cost savings on prescription drugs.
Such models gained traction due to perceived cost disparities in pharmaceuticals between nations. Patients, particularly those in countries with high drug prices, have sought avenues to procure medications at more affordable rates. The historical context involves the increasing globalization of markets and the expansion of internet commerce, enabling cross-border pharmaceutical transactions. However, the legitimacy and safety of these operations have been subject to scrutiny and regulatory oversight.
